Cite
HARVARD Citation
Cabibbo, G. et al. (n.d.). Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Digestive and liver disease. 49 (1), pp. e59-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cabibbo, G. et al. (n.d.). Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Digestive and liver disease. 49 (1), pp. e59-. [Online].